# Fidelity National Financial, Inc.: financial statements, quarterly

FNF · NYSE · CIK 1331875 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnf.md) · [Financials](/companies/fnf/financials.md) · [Filings](/companies/fnf/filings.md) · [Insiders](/companies/fnf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [501](/filings/0001331875-24-000060.md) | [430 d](/filings/0001331875-26-000026.md) | [421](/filings/0001331875-25-000033.md) | [504](/filings/0001331875-25-000055.md) | [506](/filings/0001331875-25-000111.md) | [493 d](/filings/0001331875-26-000026.md) | [455](/filings/0001331875-26-000042.md) | [547](/filings/0001331875-26-000073.md) | [553](/filings/0001331875-25-000111.md) | [544 d](/filings/0001331875-26-000026.md) | [506](/filings/0001331875-26-000042.md) | [604](/filings/0001331875-26-000073.md) |
| Interest expense | $m | [44.0](/filings/0001331875-24-000060.md) | [45.0 d](/filings/0001331875-25-000013.md) | [49.0](/filings/0001331875-25-000033.md) | [47.0](/filings/0001331875-25-000055.md) | [56.0](/filings/0001331875-24-000060.md) | [57.0 d](/filings/0001331875-25-000013.md) | [60.0](/filings/0001331875-25-000033.md) | [61.0](/filings/0001331875-25-000055.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [141](/filings/0001331875-24-000060.md) | [(53.0) d](/filings/0001331875-26-000026.md) | [63.0](/filings/0001331875-25-000033.md) | [116](/filings/0001331875-25-000055.md) | [44.0](/filings/0001331875-25-000111.md) | [144 d](/filings/0001331875-26-000026.md) | [29.0](/filings/0001331875-26-000042.md) | [98.0](/filings/0001331875-26-000073.md) | [90.0](/filings/0001331875-25-000111.md) | [536 d](/filings/0001331875-26-000026.md) | [175](/filings/0001331875-26-000042.md) | [63.0](/filings/0001331875-26-000073.md) |
| Net income | $m | [426](/filings/0001331875-24-000060.md) | [(69.0) d](/filings/0001331875-26-000026.md) | [248](/filings/0001331875-25-000033.md) | [306](/filings/0001331875-25-000055.md) | [266](/filings/0001331875-25-000111.md) | [450 d](/filings/0001331875-26-000026.md) | [83.0](/filings/0001331875-26-000042.md) | [278](/filings/0001331875-26-000073.md) | [358](/filings/0001331875-25-000111.md) | [(117) d](/filings/0001331875-26-000026.md) | [243](/filings/0001331875-26-000042.md) | [288](/filings/0001331875-26-000073.md) |
| Diluted EPS | $ per share | [1.57](/filings/0001331875-23-000059.md) | not reported | [0.91](/filings/0001331875-25-000033.md) | [1.12](/filings/0001331875-25-000055.md) | [0.97](/filings/0001331875-25-000111.md) | not reported | [0.30](/filings/0001331875-26-000042.md) | [1.02](/filings/0001331875-26-000073.md) | [1.33](/filings/0001331875-25-000111.md) | not reported | [0.90](/filings/0001331875-26-000042.md) | [1.08](/filings/0001331875-26-000073.md) |
| Basic EPS | $ per share | [1.58](/filings/0001331875-23-000059.md) | not reported | [0.92](/filings/0001331875-25-000033.md) | [1.13](/filings/0001331875-25-000055.md) | [0.98](/filings/0001331875-25-000111.md) | not reported | [0.30](/filings/0001331875-26-000042.md) | [1.02](/filings/0001331875-26-000073.md) | [1.33](/filings/0001331875-25-000111.md) | not reported | [0.90](/filings/0001331875-26-000042.md) | [1.08](/filings/0001331875-26-000073.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.2](/filings/0001331875-23-000059.md) | [2.8](/filings/0001331875-25-000013.md) | [3.5](/filings/0001331875-24-000029.md) | [4.9](/filings/0001331875-24-000049.md) | [5.0](/filings/0001331875-24-000060.md) | [3.5](/filings/0001331875-26-000026.md) | [4.5](/filings/0001331875-25-000033.md) | [3.3](/filings/0001331875-25-000055.md) | [3.5](/filings/0001331875-25-000111.md) | [2.6](/filings/0001331875-26-000073.md) | [2.5](/filings/0001331875-26-000042.md) | [3.6](/filings/0001331875-26-000073.md) |
| Total assets | $bn | [74.0](/filings/0001331875-24-000060.md) | [80.6](/filings/0001331875-26-000026.md) | [84.5](/filings/0001331875-25-000033.md) | [88.8](/filings/0001331875-25-000055.md) | [94.7](/filings/0001331875-25-000111.md) | [95.3](/filings/0001331875-26-000026.md) | [98.2](/filings/0001331875-26-000042.md) | [102](/filings/0001331875-26-000073.md) | [107](/filings/0001331875-25-000111.md) | [109](/filings/0001331875-26-000073.md) | [111](/filings/0001331875-26-000042.md) | [115](/filings/0001331875-26-000073.md) |
| Total liabilities | $bn | [67.4](/filings/0001331875-23-000059.md) | [73.2](/filings/0001331875-25-000013.md) | [76.7](/filings/0001331875-24-000029.md) | [80.8](/filings/0001331875-24-000049.md) | [85.8](/filings/0001331875-24-000060.md) | [86.7](/filings/0001331875-26-000026.md) | [89.4](/filings/0001331875-25-000033.md) | [93.5](/filings/0001331875-25-000055.md) | [97.3](/filings/0001331875-25-000111.md) | [100](/filings/0001331875-26-000073.md) | [103](/filings/0001331875-26-000042.md) | [106](/filings/0001331875-26-000073.md) |
| Long-term debt | $bn | [3.7](/filings/0001331875-23-000059.md) | [3.9](/filings/0001331875-25-000013.md) | [3.9](/filings/0001331875-24-000029.md) | [4.2](/filings/0001331875-24-000049.md) | [4.2](/filings/0001331875-24-000060.md) | [4.3](/filings/0001331875-26-000026.md) | [4.4](/filings/0001331875-25-000033.md) | [4.4](/filings/0001331875-25-000055.md) | [4.4](/filings/0001331875-25-000111.md) | [4.4](/filings/0001331875-26-000073.md) | [4.4](/filings/0001331875-26-000042.md) | [4.4](/filings/0001331875-26-000073.md) |
| Shareholders' equity | $bn | [6.2](/filings/0001331875-23-000059.md) | [6.9](/filings/0001331875-25-000013.md) | [7.1](/filings/0001331875-24-000029.md) | [7.3](/filings/0001331875-24-000049.md) | [8.1](/filings/0001331875-24-000060.md) | [7.8](/filings/0001331875-26-000026.md) | [7.9](/filings/0001331875-25-000033.md) | [7.9](/filings/0001331875-25-000055.md) | [8.4](/filings/0001331875-25-000111.md) | [7.4](/filings/0001331875-26-000073.md) | [7.3](/filings/0001331875-26-000042.md) | [7.5](/filings/0001331875-26-000073.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,076 d](/filings/0001331875-24-000060.md) | [2,263 d](/filings/0001331875-26-000026.md) | [1,591](/filings/0001331875-25-000033.md) | [1,363 d](/filings/0001331875-25-000055.md) | [2,366 d](/filings/0001331875-25-000111.md) | [1,495 d](/filings/0001331875-26-000026.md) | [1,115](/filings/0001331875-26-000042.md) | [1,896 d](/filings/0001331875-26-000073.md) | [1,311 d](/filings/0001331875-25-000111.md) | [1,506 d](/filings/0001331875-26-000026.md) | [875](/filings/0001331875-26-000042.md) | [1,871 d](/filings/0001331875-26-000073.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [123 d](/filings/0001331875-24-000060.md) | [134 d](/filings/0001331875-26-000026.md) | [130](/filings/0001331875-25-000033.md) | [131 d](/filings/0001331875-25-000055.md) | [130 d](/filings/0001331875-25-000111.md) | [141 d](/filings/0001331875-26-000026.md) | [136](/filings/0001331875-26-000042.md) | [135 d](/filings/0001331875-26-000073.md) | [135 d](/filings/0001331875-25-000111.md) | [140 d](/filings/0001331875-26-000026.md) | [140](/filings/0001331875-26-000042.md) | [138 d](/filings/0001331875-26-000073.md) |
| Share repurchases | $m | [0.0 d](/filings/0001331875-24-000060.md) | [0.0 d](/filings/0001331875-26-000026.md) | [0.0](/filings/0001331875-25-000033.md) | [0.0 d](/filings/0001331875-25-000055.md) | [0.0 d](/filings/0001331875-25-000111.md) | [0.0 d](/filings/0001331875-26-000026.md) | [24.0](/filings/0001331875-26-000042.md) | [154 d](/filings/0001331875-26-000073.md) | [43.0 d](/filings/0001331875-25-000111.md) | [30.0 d](/filings/0001331875-26-000026.md) | [78.0](/filings/0001331875-26-000042.md) | [60.0 d](/filings/0001331875-26-000073.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [275](/filings/0001331875-23-000059.md) | [271](/filings/0001331875-24-000029.md) | [271](/filings/0001331875-24-000049.md) | [271](/filings/0001331875-24-000060.md) | [272](/filings/0001331875-25-000033.md) | [273](/filings/0001331875-25-000055.md) | [273](/filings/0001331875-25-000111.md) | [273](/filings/0001331875-26-000042.md) | [273](/filings/0001331875-26-000073.md) | [270](/filings/0001331875-25-000111.md) | [269](/filings/0001331875-26-000042.md) | [267](/filings/0001331875-26-000073.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 268,192,827 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001331875-26-000073.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.